Director of Business Development at Civica Rx

About Civica:

Over the past two decades, shortages of generic, injectable medications critical to the lifesaving work of hospitals in the United States have become commonplace and have reached an all time high. Over 300 essential medications are reported to be in shortage, according to industry and FDA reports. "Race to the bottom" pricing of mostly sterile injectable medications, manufacturing challenges and predatory pricing are both the causes and results.

Who suffers most? Patients.

Civica is a 501(c)(4) social welfare organization established in 2018 by health systems (CommonSpirit Health, HCA Healthcare, Intermountain Healthcare, Mayo Clinic, Providence St. Joseph Health, SSM Health, and Trinity Health) and philanthropies (Gary and Mary West Foundation, Laura and John Arnold Foundation, and Peterson Center on Healthcare) to reduce chronic generic drug shortages and related high prices in the United States. An experienced team of health care and pharmaceutical industry leaders leads the organization.

Today, more than 55 health systems have joined Civica. They represent over 1,500 hospitals and over 30 percent of all U.S. hospital beds. Civica has also supplied the U.S. Department of Veteran's Affairs, the U.S. Department of Defense, and the U.S. Strategic National Stockpile of essential medicines. Since established, the #1 Policy for the Civica team has been "Do What Is in the Best Interest of Patients."

Civica has expanded its mission beyond the hospital setting to include lowering the cost of medications at the pharmacy counter. It has launched a sister organization, CivicaScript, to enter the retail pharmacy market partnering with Blue Cross Blue Shield entities and others with the goal of reducing select high cost generic drugs where market forces are not working to control drug costs.

More recently, Civica announced plans to develop, manufacture and deliver affordable biosimilar insulin, The consistent availability of affordable insulin will benefit people who ration their care or who have been forced to choose between this life-sustaining medicine and living expenses. Those who are uninsured or underinsured often pay the most out of pocket for their medications.

Long- and short-acting insulins will be produced and available in both vials and pre-filled pens - at no more than $30 per vial and no more than $55 for a pack of five pens.

Learn more about Civica's plans and progress at www.civicarx.org

Position Summary

Reporting to the Chief Commercial Officer, the Director will lead certain business development activities for the organization, working in the generic pharmaceutical field, including identifying and evaluating potential opportunities and personal involvement with strategic partners. The Director, Business Development be responsible for development/execution, tracking and reporting of current and new business development pipeline and management to financial and performance objectives. The Director, Business Development will play a key role in shaping the future commercial strategy for the business.

Essential Duties and Responsibilities

• Develop strategies and find business opportunities to support our mission of reducing drug shortages and making medications accessible and affordable.
• Continually evaluate, along with the Vice President of Portfolio Management, our product portfolio to meet our member hospital's needs.
• Continually evaluate the product portfolio to meet the CivicaScript mission of affordable generic medications for consumers.
• Build and maintain strong, sustainable relationships with strategic business partners and our member hospitals.
• Use data analysis and market research to drive decisions.
• Demonstrate behaviors consistent with Civica's values guiding principles.

Minimum Qualifications (Knowledge, Skills, and Abilities)

• A minimum of 10 years of relevant industry experience including extensive experience in Business Development for generic pharmaceuticals plus additional experience in allied fields such as Supply Chain, Marketing, R&D, Pharmacy, etc.
• Bachelor's degree required; master's degree preferred.
• Excellent communication skills.
• Strategic thinking skills to analyze business opportunities, create market landscapes and identify alternatives.
• Skilled at prospecting business opportunities then developing and negotiating terms.
• Work with Legal to develop, negotiate and execute contracts
• Use public databases like the FDA Orange Book or purchased databases like IQVIA to develop market landscapes and analyze drug markets.
• Lead cross functional teams to integrate new opportunities into the company
• Identifying generic pharmaceuticals that fit Civica's mission
• Identify sources for generic pharmaceuticals, components, and other needs of the business
• Identify and research potential partners.
• Build and manage relationships with partners.
• Experienced at negotiating business relationships with a demonstrated background in leading negotiations and closing deals.
• Must be an energetic self-starter who can work independently with a strong work ethic and develop structure when working with new opportunities.
• General computer proficiency including Microsoft Office Suite (Word, Outlook, Excel, PowerPoint) and databases such as IQVIA.
• Willing to travel, approx. 20%.

PandoLogic. Keywords: Business Development Director, Location: Petersburg, VA - 23803 , PL: 595049840